Jerry W. Simecka

OverviewAI-generated summary

Jerry W. Simecka's research has focused on host-pathogen interactions, particularly in the context of respiratory infections in animal models. His work has investigated the roles of innate and adaptive immunity in Mycoplasma pulmonis respiratory disease in mice, examining the gene expression and production of key inflammatory cytokines such as tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon. Simecka has also explored the impact of T cell depletion on disease progression, noting that the depletion of CD8+ T cells can exacerbate CD4+ Th cell-associated inflammatory lesions during murine Mycoplasma respiratory disease.

Further investigations by Simecka have included studies on adenoviral gene delivery to the lungs, assessing the systemic and mucosal immune responses elicited by the vector and its transgene. This work has involved evaluating the induction of IgG and IgA antibodies. Additionally, his research has touched upon bacterial mechanisms, including the regulation of biofilm formation and motility in Escherichia coli, with a focus on the role of the global regulator CsrA and catabolite repression.

With 109 total publications and an h-index of 37, Simecka is recognized as a highly cited researcher. He has collaborated with colleagues such as Brian D. Piccolo on shared publications. His recent activity indicates ongoing engagement in research.

Metrics

• h-index: 37
• Publications: 110
• Citations: 3,812